Showing posts with label Mouse. Show all posts
Showing posts with label Mouse. Show all posts

Friday, February 19, 2016

VEGF-A Across Species

Kingfisher Biotech's portfolio of VEGF-A recombinant proteins includes,  bovine,  canine, equine,  feline,  mouse,  ovine,  rabbit , rat,  swine, and zebrafish VEGF-A.

Vascular endothelial growth factor (VEGF) proteins stimulate vasculogenesis and angiogenesis. They are part of the system that restores the oxygen supply to tissues when blood circulation is inadequate. The normal function of VEGF proteins is to create new blood vessels during embryonic development, new blood vessels after injury, muscle following exercise, and new vessels (collateral circulation) to bypass blocked vessels. The VEGF family has six members, including VEGF-A, VEGF-B, VEGF-C, VEGF-D, VEGF-E, and Placental Growth Factor (PGF). Activity of VEGF-A, as its name implies, has been studied mostly on cells of the vascular endothelium, although it does have effects on a number of other cell types (e.g., stimulation monocyte/macrophage migration, neurons, cancer cells, kidney epithelial cells). In vitro, VEGF-A has been shown to stimulate endothelial cell mitogenesis and cell migration. VEGF-A is also a vasodilator and increases microvascular permeability and was originally referred to as vascular permeability factor (VPF).

A recent bioassay of our bovine, canine, and mouse VEGF-A based on the proliferation of HUVECs demonstrated that all three proteins are highly active on the human cell line.



Monday, February 1, 2016

Our Newest Proteins - 2/1/2016

Kingfisher Biotech, Inc. is committed to accelerating basic veterinary research and human disease research done in animal models by developing and commercializing research reagents specific for a variety of species. We will continue to add species as our customer request specific reagents for their research. Currently, we offer over 1500 recombinant proteins, polyclonal antibodies, monoclonal antibodies and ELISA kits for animal health and animal model research. Our products are primarily cytokines, chemokines, interferons, and growth factors. Our product development queue is filled mainly by customer requests. If there is a product that you are looking for and can't find, please send us an email.


Wednesday, July 8, 2015

New Products - July 2015

Kingfisher Biotech, Inc. is committed to accelerating basic veterinary research and human disease research done in animal models by developing and commercializing research reagents specific for a variety of species, including bovine, canine, caprine, chicken, dolphin, equine, feline, guinea pig, hamster, human, mouse, ovine, rabbit, rat, swine, and turkey. We have just started adding cynomolgus monkey and zebrafish products. Currently, we offer over 1200 recombinant proteins, polyclonal antibodies, monoclonal antibodies and ELISA kits for animal health and animal model research. Our products are primarily cytokines, chemokines, interferons, and growth factors. Our product development queue is filled mainly by customer requests. If there is a product that you are looking for and can't find, please send us an email.

Below is a list of our newest recombinant proteins with links to website with additional information on each product.

Thursday, May 28, 2015

New Products - May 2015

Kingfisher Biotech, Inc. is committed to accelerating basic veterinary research and human disease research done in animal models by developing and commercializing research reagents specific for a variety of species, including bovine, canine, caprine, chicken, dolphin, equine, feline, guinea pig, hamster, human, mouse, ovine, rabbit, rat, swine, and turkey. We have just started adding cynomolgus monkey and zebrafish products. Currently, we offer over 1200 recombinant proteins, polyclonal antibodies, monoclonal antibodies and ELISA kits for animal health and animal model research. Our products are primarily cytokines, chemokines, interferons, and growth factors. Our product development queue is filled mainly by customer requests. If there is a product that you are looking for and can't find, please send us an email.

Below is a list of our newest recombinant proteins and specialty products with links to website with additional information on each product.

Thursday, April 16, 2015

New Recombinant Proteins - April 2015

Kingfisher Biotech, Inc. is committed to accelerating basic veterinary research and human disease research done in animal models by developing and commercializing research reagents specific for a variety of species, including bovine, canine, caprine, chicken, dolphin, equine, feline, guinea pig, hamster, human, mouse, ovine, rabbit, rat, swine, and turkey. We will continue to add species as our customer request specific reagents for their research. Currently, we offer over 1200 recombinant proteins, polyclonal antibodies, monoclonal antibodies and ELISA kits for animal health and animal model research. Our products are primarily cytokines, chemokines, interferons, and growth factors. Our product development queue is filled mainly by customer requests. If there is a product that you are looking for and can't find, please send us an email.

Below is a list of our newest proteins with links to website with additional information on each protein.

Thursday, April 9, 2015

IFN gamma Recombinant Proteins - Bovine, Canine, Chicken, Dolphin, Equine, Feline, Human, Mouse, Ovine, Rabbit, and Swine

Bovine, Canine, Chicken, Dolphin, Equine, Feline, Human, Mouse, Ovine, Rabbit, and Swine IFN gamma Recombinant Proteins

IFN-gamma, or type II interferon, is a cytokine that is critical for innate and adaptive immunity against viral and intracellular bacterial infections and for tumor control. Aberrant IFN-gamma expression is associated with a number of autoinflammatory and autoimmune diseases. The importance of IFN-gamma in the immune system stems in part from its ability to inhibit viral replication directly, but, most important, derives from its immunostimulatory and immunomodulatory effects. IFN-gamma is produced predominantly by natural killer (NK) and natural killer T (NKT) cells as part of the innate immune response, and by CD4 and CD8 cytotoxic T lymphocyte (CTL) effector T cells once antigen-specific immunity develops.

Kingfisher Biotech offers bovine, canine, chicken, dolphin, equine, feline, human, mouse, ovine, rabbit, and swine IFN gamma recombinant proteins. Our proteins are produced in yeast, making them naturally endotoxin-free - perfect for cell culture applications. 

IFN gamma Homology Across Species



Thursday, February 26, 2015

CCL5 Recombinant Proteins - Bovine, Canine, Chicken, Equne, Guinea Pig, Human, Mouse, Swine

RANTES/CCL5 recombinant proteins can be used in cell culture, as an RANTES/CCL5 ELISA Standard, and as a Western Blot Control. CCL5, also know as RANTES (regulated and normal T cell expressed and secreted) is a member of the C-C Chemokine Family. There are at least 27 distinct members of the C-C subgroup reported for mammals. RANTES (CCL5) is chemotactic for T cells, eosinophils, and basophils, and plays an active role in recruiting leukocytes into inflammatory sites. CCL5 plays a role in many disease states, including rheumatoid arthritis, HIV, and cancer. CCL5/RANTES recombinant proteins are intended for use in animal model and animal health research.

RP0062B-025
25 ug
RP0062B-005
5 ug
RP0454D-025
25 ug
RP0454D-005
5 ug
RP0982C-025
25 ug
RP0982C-005
5 ug
RP0070E-025
25 ug
RP0070E-005
5 ug
RP0348GP-025
25 ug
RP0348GP-005
5 ug
RP0983H-025
25 ug
RP0983H-005
5 ug
RP0984M-025
25 ug
RP0984M-005
5 ug
RP0059S-100
100 ug
RP0059S-025
25 ug
RP0059S-005
5 ug




Saturday, November 9, 2013

IL-34: The brains behind CSF-1R pathology in the brain and skin?

In humans, loss or gain of function in CSF-1R has been associated with many inflammatory conditions and cancers, due to its role in the maintenance of mononuclear phagocytes. In particular, the CSF-1R ligand IL-34 plays a key role in maintaining the tissue resident macrophages of the skin and brain, thus being critical to antimicrobial and other inflammatory responses at these sites. IL-34, along with CSF-1, has also been implicated in the inflammation of rheumatoid arthritis and Sjögrens, as well as a poor prognosis in many malignancies. more...

Thursday, March 21, 2013

Mouse IL-6 Bioactivity


IL-6 acts as both a pro-inflammatory and anti-inflammatory cytokine. It is secreted by T cells and macrophages to stimulate immune response to trauma, especially burns or other tissue damage leading to inflammation. IL-6 is also produced from muscle, and is elevated in response to muscle contraction. It is significantly elevated with exercise and precedes the appearance of other cytokines in the circulation. Osteoblasts secrete IL-6 to stimulate osteoclast formation. Smooth muscle cells also produce IL-6 as a pro-inflammatory cytokine. The role of IL-6 as an anti-inflammatory cytokine is mediated through its inhibitory effects on TNF-alpha and IL-1 and activation of IL-1ra and IL-10.

Kingfisher Biotech’s Mouse IL-6 (cat # RP0380M) activity was accessed and shown to be active and comparable with other commercially available Mouse IL-6 protein. This work was done by an independent lab with expertise in bioassays. Both samples of Mouse IL-6 were reconstituted with 0.1% BSA in PBS prior to assay. Kingfisher Biotech’s Mouse IL-6 protein concentration was determined by BCA. Protein determination of the competitor’s protein is unknown. Kingfisher Biotech’s mouse IL-6 was expressed in yeast so it is naturally endotoxin-free and post-translationally modified. Mouse IL-6 purchased from Competitor A was produced in E. coli.

Method
The biological activity of Kingfisher Biotech Recombinant Mouse IL-6 was verified by proliferation of 7TD1 cells, a mouse IL-6-dependant B-cell hybridoma cell line. Briefly, 7TD1 cells were incubated with various concentrations of recombinant Mouse IL-6 protein in a dose dependent manner in complete medium containing 10% calf serum and Gentamicin for 64 hours at 37°C, 5% CO2 in a 96-well tissue culture plate. Cell proliferation was measured utilizing Promega Substrate Cell Titer 96 Aqueous One Solution Reagent and measuring the optical density of the final solution at 490 nm. The ED50 of Kingfisher Biotech Recombinant Mouse IL-6 protein was determined to be 0.006-0.009 ng/ml.



Monday, November 14, 2011

TNF alpha Homology Across Species

TNF alpha is involved in systemic inflammation and is a member of a group of cytokines that stimulate the acute phase reaction. It is produced mainly by activated macrophages.

TNF alpha is able to induce fever, apoptotic cell death, sepsis (through IL-1 & IL-6 production), cachexia, and inflammation, as well as to inhibit tumorigenesis and viral replication. Because of the broad role of TNF alpha, dysregulation has been implicated in a variety of diseases.


Sunday, October 30, 2011

Rabbit as an Animal Model for Osteoarthritis Research

In humans, osteoarthritis (OA) develops either idiopathically and progresses slowly with age or secondarily to trauma and progresses rapidly. OA is associated with changes to all joint tissues including articular cartilage, subchondral bone, synovium, ligaments, and muscles. Clinically, OA-mediated joint damage results in reduced mobility, pain, and fatigue. While several disease modifying OA drugs are in various stages of development, none have yet been approved for human use. Concurrent research in humans as well as experimental animal models will be important for the discovery of new therapeutics. Since no single experimental model provides the complete picture of OA in humans, a variety of animals have served to advance OA research including mouse, rat, guinea pig, rabbit, dog, and horse. [1,2]
A broad range of rabbit OA models have been used extensively and continue to offer specific advantages over other models for OA research. The gross anatomy of the rabbit knee is very similar to that of humans. Moreover, the rabbit knee joint is large enough to enable the harvest of adequate volumes of tissue for histopathological analysis, a major limitation of smaller animal models. In adult humans, the growth plates in the long bones no longer retain the capacity for growth and are termed “closed.” This is also the case in skeletally-mature rabbits. By contrast, mouse and rat growth plates do not normally close completely and longitudinal bone growth can be reinitiated even in mature animals. This is a complicating issue for data interpretation and limits the translatability of research performed using mice and rats. [2]
Most often, skeletally-mature, male, NZW rabbits are used for OA studies in an attempt to ensure bone growth plate closure, reduce hormone fluctuation, and control for potential inter-strain variability. OA does not occur spontaneously in rabbits, but can be induced via surgical intervention (i.e., meniscectomy or anterior cruciate ligament transection [ACLT]), mechanical manipulation (i.e., impact or immobilization), or chemical application (i.e., IL-1β, collagenase, etc.). The majority of rabbit OA studies employ the ACLT model as it offers several advantages. ACLT-modified rabbits very quickly develop a wide variety of cartilage lesions post-surgically, which closely approximate many aspects of human OA. The histopathology of the rabbit ACLT model has been studied extensively and a standardized nomenclature and scoring scheme for evaluating and comparing alterations in joint structures, including changes in cartilage, synovium and bone, have been proposed. Further, a sizeable body of data derived from this model has already been amassed describing OA pathogenesis including imaging studies and effects of various potential pharmacological applications. [2]
References
1. Poole, R. et al. (2010) Recommendations for the use of preclinical models in the study and treatment of osteoarthritis. Osteoarthritis Cartilage 18(Suppl. 3):S10-S16.
2. Laverty, S. et al. (2010) The OARSI histopathology initiative – recommendations for histological assessments of osteoarthritis in the rabbit. Osteoarthritis Cartilage 18(Suppl. 3):S53-S65.